Rituximab fails to eliminate meningeal inflammation in progressive MSFebruary 1, 2018Multiple Sclerosis
Fingolimod cuts pediatric MS relapse rate more than interferon beta-1aFebruary 1, 2018Multiple Sclerosis
Preventive health: Getting rid of the middleman (uh-oh, that’s us!)January 31, 2018Business of Medicine
Study finds rising use of newer DMTs in pediatric-onset MSJanuary 31, 2018Multiple SclerosisPediatrics
